Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Alisertib | Apoptosis | Aurora Kinase | Autophagy | TargetMol
Alisertib (MLN 8237) is an Orally Active Aurora A Kinase Inhibitor for ...
Alisertib mechanism of action. Alisertib selectively binds to and ...
Chemical structure of Aurora kinase-A inhibitor alisertib (MLN8237 ...
Alisertib is an Oral Active and Selective Aurora A Kinase Inhibitor ...
Alisertib (MLN8237) | Aurora A inhibitor | Probechem Biochemicals
Aurora-A inhibitor I and Alisertib inhibit the redistribution of ...
Alisertib (MLN8237) | Aurora A Kinase inhibitor | CAS 1028486-01-2 ...
Alisertib (MLN8237) Aurora A Kinase inhibitor | Selleck Chemicals ...
Alisertib (ALS) inhibits the phosphorylation of Aurora kinase A (AURKA ...
Aurora kinase A (AURKA) inhibition with alisertib induces increases RNA ...
Characterization of Alisertib (MLN8237), an Investigational Small ...
(PDF) Phase I study of the aurora A kinase inhibitor alisertib with ...
Alisertib (MLN 8237) | Aurora A Kinase Inhibitor | MedChemExpress
Antitumor activity of the aurora a selective kinase inhibitor alisertib ...
(PDF) Enhanced Delivery of Aurora Kinase A Inhibitor Alisertib via ...
A phase II trial of the aurora kinase A inhibitor alisertib for ...
Selective Aurora-A inhibitor alisertib in clinical trails a ...
Alisertib is released from intravaginal rings in a controlled and ...
Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination ...
Alisertib Supplier | CAS 1028486-01-2 | Focus Biomolecules
Alisertib and Barasertib potently suppress the colony-formation of ...
Alisertib | MLN 8237 | Aurora A kinase inhibitor | TargetMol
Alisertib inhibits macrophages infiltration and downregulates the ...
Aurkin-A, a TPX2-aurora a small molecule inhibitor disrupts Alisertib ...
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for ...
Full article: Inhibition of Aurora Kinase A by Alisertib Reduces Cell ...
MLN8054 and Alisertib (MLN8237): Discovery of Selective Oral Aurora A ...
(PDF) Characterization of Alisertib (MLN8237), an Investigational Small ...
Investigational Aurora A kinase inhibitor alisertib (MLN8237) as an ...
Inhibition of mitotic Aurora kinase A by alisertib induces apopto | DDDT
Alisertib (MLN8237) | 阿利色替 | Aurora Kinase 抑制剂 | 现货供应 | 美国品牌 | 免费采购电话 ...
Alisertib | MLN 8237 | Aurora A 激酶抑制剂 | TargetMol
Alisertib targets aurora A kinase for potentiation of cisplatin and ...
MLN8237 (Alisertib) – Aurora Kinase A Inhibitor | APExBIO
Frontiers | Scientific Rationale Supporting the Clinical Development ...
MLN8237 (Alisertib) | Aurora A Kinase inhibitor | 1028486-01-2 | AdooQ®
Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autopha ...
Molecular docking of alisertib, aMg-900, barasertib, cYc116, and ...
美国APExBIO中文官网 - MLN8237 (Alisertib)|Aurora A Kinase inhibitor, Potent ...
An update on the pharmacokinetics and pharmacodynamics of alisertib, a ...
Combination treatment with the Aurora A inhibitor, Alisertib, and the ...
Safety and activity of alisertib, an investigational aurora kinase A ...
Antitumor activity of the aurora a selective kinase inhibitor ...
MLN8237 (Alisertib) | CAS:1028486-01-2 | Aurora A Kinase inhibitor ...
Full article: Alisertib, an Aurora kinase A inhibitor, induces ...
(PDF) Alisertib, an Aurora kinase A inhibitor, induces apoptosis and ...
Biotransformation Pathways and Metabolite Profiles of Oral [14C ...
Aurora Kinase抑制剂 | Aurora Kinase Inhibitor
Aurora A kinase inhibition enhances oncolytic herpes virotherapy ...
APExBIO - MLN8237 (Alisertib)|Aurora A Kinase inhibitor, Potent and ...
A Phase Ib Expansion Cohort Evaluating Aurora A Kinase Inhibitor ...
Phase II Study of Alisertib, a Selective Aurora A Kinase Inhibitor, in ...
Preclinical and Dose-Finding Phase I Trial Results of Combined ...
JCI - Aurora A kinase inhibition compromises its antitumor efficacy by ...
(PDF) Scientific Rationale Supporting the Clinical Development Strategy ...
Murine Central Nervous System and Bone Marrow Distribution of the ...